S. Gunalp Et Al. , "TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content," FRONTIERS IN IMMUNOLOGY , vol.14, 2023
Gunalp, S. Et Al. 2023. TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content. FRONTIERS IN IMMUNOLOGY , vol.14 .
Gunalp, S., Helvaci, D. G., Oner, A., Bursalı, A., Conforte, A., GÜNER, H., ... KARAKÜLAH, G.(2023). TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content. FRONTIERS IN IMMUNOLOGY , vol.14.
Gunalp, Sinem Et Al. "TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content," FRONTIERS IN IMMUNOLOGY , vol.14, 2023
Gunalp, Sinem Et Al. "TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content." FRONTIERS IN IMMUNOLOGY , vol.14, 2023
Gunalp, S. Et Al. (2023) . "TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content." FRONTIERS IN IMMUNOLOGY , vol.14.
@article{article, author={Sinem Gunalp Et Al. }, title={TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content}, journal={FRONTIERS IN IMMUNOLOGY}, year=2023}